Abiopharma

🔍 KNUTSON PAUL L (Executive)

Company: Otter Tail Corp (OTTR)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 3,500 shares of Common Stock at $93.11 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,495.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 725 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: G | equity_swap_involved: 0 | shares_owned_after: 20,770.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 475 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: G | equity_swap_involved: 0 | shares_owned_after: 475.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 250 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: G | equity_swap_involved: 0 | shares_owned_after: 250.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: $93.11 is the weighted average sales price of the shares sold. These shares were sold in multiple transactions at prices ranging from $92.74 to $93.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Total direct holdings include shares acquired individually through dividend reinvestment, Employee Stock Purchase Plan, and acquired pursuant to Restricted Stock Awards and Performance Share Awards.
• F3: This transaction involved the reporting person's gift of 475 shares of common stock to his daughter and 250 shares of common stock to his son.